2 not yet recruiting, 1 active not recruiting, 1 completed. 3 Phase 3, 2 Phase 2.
| Phase | Trials | Status |
|---|---|---|
| Phase 3 | 3 | Active not recruiting 1, Completed 1, Not yet recruiting 1 |
| Phase 2 | 2 | Not yet recruiting 2 |
Follow TLL-018 tablets: new trials by email Literature Review of TLL-018 tablets trials Research Report on TLL-018 tablets
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| A Study of Efficacy and Safety of TLL-018 in CSU Participants With Inadequate Response to 2nd-generation H1-AHs TLL-018 tablets, Placebo - Chronic Spontaneous Urticaria (CSU) | Phase 2 | Not yet recruiting | Hangzhou Highlightll Pharmaceutical Co., Ltd | 140 | 2026-09-10 | 2026-08-24 |
| A Study to Evaluate the Efficacy, Safety, and Pharmacokinetic Profiles of TLL-018 in Patients With Moderate-to-Severe Atopic Dermatitis TLL-018 tablets, Placebo - Atopic Dermatitis (AD) | Phase 2 / Phase 3 | Not yet recruiting | Hangzhou Highlightll Pharmaceutical Co., Ltd | 390 | 2026-08-31 | 2026-08-25 |
| A Study of Efficacy and Safety of TLL-018 in CSU Participants TLL-018 tablets, Placebo tablets - Chronic Spontaneous Urticaria | Phase 3 | Active not recruiting | Hangzhou Highlightll Pharmaceutical Co., Ltd | 440 | 2024-03-27 | 2026-06-03 |
| A Phase 3 Study Comparing TLL-018 to Tofacitinib in RA Subjects With Inadequate Response or Intolerance to bDMARDs TLL-018, Tofacitinib - Rheumatoid Arthritis | Phase 3 | Completed | Hangzhou Highlightll Pharmaceutical Co., Ltd | 459 | 2023-11-15 | 2026-09-25 |
Chronic Urticaria (2) · Arthritis, Rheumatoid (1) · Dermatitis, Atopic (1)
Hangzhou Highlightll Pharmaceutical Co., Ltd (4)
China (3)